Is Amgen Inc. overvalued?

Amgen Inc. (AMGN) looks overvalued — trading about 23% above its fair value.

Overvalued

Price

$416.18

Fair value

$321.03

Current P/E

29.2

Normal P/E

22.6

Market cap

$224.62B

Dividend yield

2.4%

Return on equity

89.3%

Sector

Healthcare

Fair value compares AMGN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks